从高价收购到1元抛售，跨界医疗与光伏的梦想在残酷现实面前碎成一地。"1元清仓大甩卖"，这样的标 签不仅出现在夜市地摊，更出现在一家A股上市公司的资产转让公告中。 2025年12月30日，永和智控宣布拟以1元价格第六次挂牌转让旗下光伏公司泰兴普乐51%股权及债权， 距离首次挂牌价3049万元，降幅接近100%。 这不是孤例。过去一年内，永和智控多次挂牌转让旗下肿瘤医院股权，其中达州医科肿瘤医院和西安医 科肿瘤医院的挂牌价也一度降至1元，却依然无人接盘。 市场无情地回应了这场跨界野心——三年来公司累计亏损4.79亿元，资产负债率从上市初的12.8%飙升 至73.24%，实控人曹德莅三次筹划易主均以失败告终。 01 跨界"大跃进"：医疗光伏双折戟，资产1元甩卖仍难出手 永和智控的跨界之路始于2019年，随着新任实控人曹德莅入主，这家以阀门管件为主业的公司开始激进 转型。公司相继收购多家肿瘤医院，包括达州、昆明、凉山、西安等地项目，总耗资超2.4亿元，这些 医院在被收购时已处于亏损状态。 2022年，公司又通过增资控股泰兴普乐切入光伏赛道，试图抓住新能源风口。跨界并未带来预期的增 长。昆明医科肿瘤医院2025年前七个 ...

1月6日，永和智控涨5.14%，截至发稿，报6.55元/股，成交1.23亿元，换手率4.46%，总市值28.93亿 元。 资料显示，永和流体智控股份有限公司位于浙江省台州市玉环市清港镇工业产业集聚区，成立日期2003 年8月28日，上市日期2016年4月28日，公司主营业务涉及医疗健康产业、流体智控业务。主营业务收入 构成为：阀门管件类89.41%，医疗服务及其他产业10.57%，光伏电池片0.02%。 截至发稿，王勇累计任职时间2年314天，现任基金资产总规模9317.82万元，任职期间最佳基金回报 82.7%， 任职期间最差基金回报-3.09%。 关旭累计任职时间2年102天，现任基金资产总规模3.59亿元，任职期间最佳基金回报35.84%， 任职期 间最差基金回报12.26%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从基金十大重仓股角度 数据显示，益民基金旗下1只基金重仓永和智控。益民核心增长混合（560006）三季度持有股数4.95万 ...

Core Viewpoint - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Chengdu Mountain Water Hotel Co., Ltd. and the debt owed by Chengdu Yonghe Cheng Medical Technology Co., Ltd. to Chengdu Mountain Water, with a minimum initial listing price of 185 million yuan, aiming to optimize asset structure, improve cash flow, and enhance asset operation efficiency [1][2]. Group 1: Company Actions - The company is transferring the equity and debt to improve its asset structure and cash flow [1]. - This is not the first time the company has attempted to transfer Chengdu Mountain Water, as previous attempts were made in late 2024 to early 2025, but those transactions did not succeed [2]. - The company has been divesting from its underperforming assets in the tumor precision radiation treatment and photovoltaic sectors, including multiple hospitals and its stake in Puluo Technology [3]. Group 2: Financial Performance - As of July 2025, Chengdu Mountain Water had total assets of 108 million yuan, total liabilities of 126 million yuan, and negative equity of 1.77 million yuan [2]. - For the fiscal year 2024, Chengdu Mountain Water reported revenue of 19.51 million yuan and a net profit of 3.52 million yuan, with revenue and net profit for the first seven months of this year at 9.59 million yuan and 1.42 million yuan, respectively [2]. - Yonghe Intelligent Control reported a revenue of 582 million yuan for the first three quarters of this year, a year-on-year decrease of 7.25%, and a net loss of 60.46 million yuan [3].

Core Viewpoint - Yonghe Fluid Control Co., Ltd. (永和智控) is undergoing a significant change in control as its major shareholder, Cao Deli, transfers shares to Hangzhou Runfeng Intelligent Equipment Co., Ltd. for a total of approximately 320 million yuan, marking a shift in the company's leadership [1][2][5]. Share Transfer Details - Cao Deli signed a share transfer agreement on August 5, 2023, transferring 35.66 million shares (8% of total shares) at a price of 8.9736 yuan per share [1][5]. - Following the transfer, Hangzhou Runfeng will hold 8% of Yonghe's shares and 14.65% of voting rights, making it the new controlling shareholder [2][5]. - The share transfer price represents a premium of over 45% compared to Yonghe's closing price on August 6, 2023 [5]. Historical Context - This is not the first time Yonghe has sought a new controlling party; previous attempts included a planned transfer to Guangdong Pulu Green Energy Holdings in 2023, which ultimately fell through [6][7]. - The current transaction mirrors the previous one in terms of share price and quantity, indicating Cao Deli's persistent efforts to divest control [8]. Company Performance and Business Focus - Yonghe's main business includes plumbing valves and fittings, which account for 85% of its revenue, while its medical and photovoltaic businesses contribute 14.39% and 0.24%, respectively [9]. - Despite efforts to diversify into the medical and photovoltaic sectors, these ventures have not yielded significant profits, with medical revenue declining by 19.77% in 2024 and photovoltaic revenue being negligible [10][11]. Future Plans - Cao Deli has committed to facilitating the divestment of Yonghe's underperforming photovoltaic and medical assets by December 20, 2025, as part of the share transfer agreement [12].

Core Viewpoint - The article discusses the recent transfer of control at Yonghe Fluid Intelligent Control Co., Ltd. (Yonghe Zhikong), highlighting the sale of shares by its controlling shareholder, which has led to significant stock price fluctuations and reflects ongoing challenges in the company's strategic direction and performance [1][4][10]. Group 1: Share Transfer Details - Yonghe Zhikong's controlling shareholder, Cao Deli, signed a share transfer agreement with Hangzhou Runfeng, transferring 35.66 million shares (8% of total shares) at a price of 8.9736 yuan per share, totaling approximately 320 million yuan [1][4]. - Following the transfer, Hangzhou Runfeng will hold 8% of Yonghe Zhikong's shares and 14.65% of voting rights, making it the new controlling shareholder [1][4]. - The share transfer price represents a premium of over 45% compared to Yonghe Zhikong's closing price on August 6 [4]. Group 2: Historical Context and Previous Attempts - This is not the first time Yonghe Zhikong has sought a new controlling shareholder; previous attempts included a planned transfer to Guangdong Pule Green Energy Holdings, which ultimately fell through [4][5][6]. - Cao Deli's persistent efforts to divest control indicate a strategic shift, as he has been involved in multiple capital operations since taking control in November 2019 [4][6]. Group 3: Business Performance and Challenges - Yonghe Zhikong's main business segments include plumbing valves (85% of revenue), precision radiation therapy (14.39%), and photovoltaic (0.24%) [8]. - The company's foray into the medical field has not yielded significant results, with medical revenue dropping by 19.77% in 2024 compared to 2023, and a low gross margin of 7.96% [9]. - The photovoltaic segment has also underperformed, generating less than 20 million yuan in revenue in 2024, with a gross margin of -3020.96% [9][10]. Group 4: Future Outlook - Cao Deli has committed to facilitating the divestment of Yonghe Zhikong's underperforming photovoltaic and medical assets by December 20, 2025, as part of the control transfer agreement [10].

Core Viewpoint - The controlling shareholder of Yonghe Intelligent Control, Cao Deli, is transferring 35.66 million shares (8.00% of total shares) to Hangzhou Runfeng at a price of 8.9736 yuan per share, totaling 320 million yuan, which has led to a significant drop in the company's stock price following the announcement [1][2][3]. Group 1: Share Transfer and Control Change - Cao Deli and Yu Yaqin collectively controlled 46.73 million shares (10.49% of total shares) before the transfer [2]. - After the transfer, Hangzhou Runfeng will hold 8.00% of Yonghe Intelligent Control, and its actual controller, Sun Rongxiang, will have voting rights for 14.65% of the shares [3]. - The transfer does not trigger a mandatory takeover and is not classified as a related party transaction [3]. Group 2: Business Restructuring - Yonghe Intelligent Control plans to divest its medical and photovoltaic segments by December 20, 2023, as part of a restructuring effort [4]. - The company has reported consecutive annual losses from 2022 to 2024, with net profits of -26.70 million yuan, -156 million yuan, and -297 million yuan, indicating a worsening trend [4]. - The anticipated revenue for the first half of 2025 is projected between 330 million yuan and 380 million yuan, with expected losses of 30 million to 56 million yuan [4]. Group 3: Legal Issues - Yonghe Intelligent Control and its subsidiaries have been involved in multiple lawsuits, with a total amount of 64.83 million yuan in undisclosed litigation over the past 12 months, exceeding 10% of the company's latest audited net assets [5]. Group 4: Hangzhou Runfeng Background - Hangzhou Runfeng was established on July 22, 2023, with a registered capital of 20 million yuan, focusing on intelligent manufacturing equipment and robotics [6]. - The company has not yet engaged in any related business activities and plans to change its business scope within 10 working days [6]. - The controlling shareholder of Hangzhou Runfeng, Hangzhou Yuli Enterprise Management, was formed on July 14, 2023, and is linked to Sun Rongxiang, who holds a 35% stake in Zhejiang Yuli Electromechanical Technology [6][7].

Core Viewpoint - The stock price of Yonghe Intelligent Control (002795.SZ) dropped by 5.80% after the announcement of a share transfer agreement involving its controlling shareholder, Cao Deli, who plans to transfer 35.66 million shares (8.00% of total shares) to Hangzhou Runfeng at a price of 8.9736 yuan per share, totaling 320 million yuan [1][2]. Group 1: Share Transfer and Control Change - Cao Deli, the current controlling shareholder, will transfer his shares to Hangzhou Runfeng, which will result in Sun Rongxiang becoming the new controlling person of Yonghe Intelligent Control [2][3]. - After the share transfer, Hangzhou Runfeng will hold 8.00% of Yonghe Intelligent Control, and Sun Rongxiang will have voting rights corresponding to 14.65% of the shares [3]. - The share transfer does not trigger a mandatory tender offer and is not classified as a related party transaction, ensuring that the company's main business operations will not undergo significant changes [3]. Group 2: Business Operations and Financial Performance - Yonghe Intelligent Control's main business includes plumbing valves and tumor precision radiation therapy, with plans to divest from the photovoltaic and medical sectors by December 20, 2023 [4]. - The company has experienced declining performance over the past three years, with net losses of 26.70 million yuan in 2022, 156 million yuan in 2023, and an expected loss of 297 million yuan in 2024 [4]. - The revenue forecast for the first half of 2025 is between 330 million yuan and 380 million yuan, with anticipated net losses ranging from 30 million yuan to 56 million yuan due to decreased income from valve business and rising costs [4]. Group 3: Legal Issues and Company Background - Yonghe Intelligent Control and its subsidiaries are involved in multiple lawsuits, with a total amount of 64.83 million yuan in undisclosed litigation over the past twelve months, exceeding 10% of the company's latest audited net assets [5]. - Hangzhou Runfeng, established on July 22, 2023, has not yet commenced its intended business operations and will change its business scope shortly [6]. - The controlling shareholder of Hangzhou Runfeng, Zhejiang Yuli Electromechanical Technology Co., has been reported to be in a state of suspension since April 2023, raising concerns about the stability of the new controlling entity [7].

Group 1: IPO Guidance and Trends - In May, the China Securities Regulatory Commission (CSRC) disclosed 17 companies undergoing IPO guidance, bringing the total for 2025 to 123 companies [1] - The number of newly disclosed companies for guidance in May decreased compared to the previous months, with 32, 29, 23, and 22 companies in January to April respectively [1] - Notable companies disclosed in the last week of May include Huaxin New Materials, Tianhai Fluid Control, Chengdu Ultra-Pure Materials, and Chengfeng Technology [1] Group 2: Huaxin New Materials - Huaxin New Materials is the fourth globally and the first domestically to achieve mass production of high-performance polyimide (PI) films, filling a domestic gap and achieving import substitution [2] - The company was established in 2019 with a registered capital of 105 million yuan and has undergone five rounds of financing, attracting investments from notable institutions such as CRRC Capital and National Development Bank [3][4][5][6] - The company completed its IPO guidance registration with Guotai Junan Securities on May 28 [2] Group 3: Tianhai Fluid Control - Tianhai Fluid Control submitted its IPO guidance materials to the Anhui Securities Regulatory Bureau on May 21, with the application accepted on May 28 [7][8] - The company, established in 2012, has seen revenue growth from 2022 to 2024, with figures of 202 million yuan, 253 million yuan, and 287 million yuan respectively, showing year-on-year growth rates of 32.4%, 25.2%, and 13.3% [9] - Tianhai Fluid previously submitted an IPO application in December 2023 but was not accepted due to issues related to shareholding [9] Group 4: Chengdu Ultra-Pure Materials - Chengdu Ultra-Pure submitted its IPO guidance to the Sichuan Securities Regulatory Bureau on May 30, which was accepted [10] - Established in 2005, the company specializes in semiconductor etching devices and high-power laser devices, with a focus on advanced surface treatment processes [10] - The company has completed four rounds of financing, with significant participation from investors including BYD and TCL Venture Capital [11][12] Group 5: Chengfeng Technology - Chengfeng Technology submitted its IPO guidance materials on May 29, which were accepted by the Sichuan Regulatory Bureau [13] - The company, founded in 2009, specializes in the research, manufacturing, and sales of valves, with a significant portion of its revenue coming from domestic sales [14][15] - Despite a decline in net profit over the past two years, the company remains a key player in the valve market, ranking third in the sales of certain valve types [15]